Psychiatry

Sleep apnea is associated with pulmonary, cardiovascular, psychiatric, neurologic, and weight-related effects. Primary care physicians need to monitor sleep health more.

A study presented at APA 2019 found that esketamine spray to be an effective, fast-acting treatment for people with treatment-resistant depression.

In a study presented at Digestive Disease Week 2019, results indicated the risk of developing Parkinson's disease was 3 times higher in patients who had appendectomies.

Mental health disorders are highly prevalent in certain patients with COPD—and their effect can limit lung function therapy benefit.

Self-reported vision impairment was associated with a greater risk of developing depression and anxiety symptoms in patients 65 and older.

Patients diagnosed with psoriasis face a nearly three-fold greater risk of developing anxiety disorders.

Assaults have become common in emergency departments. Organizers and individuals are calling on caregivers and administrators to collaborate on real solutions.

The investigative drug SEP-363856 has been evidenced in a phase 2 trial to reduced hospitalized patient symptoms and severity.

Esketamine nasal spray is currently relegated to a specific depression patient population, but that may not be for long.

From 2010 to 2017, there was an increase of over 30% in the number of commercially insured children being diagnosed with ADHD.

The selective serotonin inverse agonist, previously approved for Parkinson symptoms, could soon seek FDA approval as an adjunctive therapy.

The FDA approved the Monarch electronic Trigeminal Nerve Stimulation based on the findings of a trial involving children aged 7-12 years old.

A new study of 55 million insured young adults in the US found that major depression, type 2 diabetes, and other conditions are becoming more prevalent among them.

A retroactive review of patients referred to a psychiatric consultant found that most patients left with a different diagnosis.

A new study shows that a history of anxiety and depression drive suicidal thoughts in students, but having a significant other may limit such thoughts.

Investigators reviewed 347 published articles and found that physician suicide, while a significant problem, is poorly understood and identified multiple possible interventions that could help.

Sleep habits are an overlooked aspect of primary care visits, despite the prevalence and burden of conditions such like insomnia on the general population.

Both long-acting injectable treatments produced statistically significant and clinically meaningful improvements.

A study of 41 patients in a single center show novel results for the recently-approved treatment-resistant depression therapy.

An extended-release, subcutaneous injection form of buprenorphine (Sublocade) demonstrated long-term efficacy and safety results.

The three-minute device complements the company's marketed TMS devices which provide care over 37.5 and 19 minutes per session.

Before the new treatment-resistant depression therapy reaches the market, Iosifescu anticipates its benefits and limitations in real-world patients.

A fourth phase 3 study of investigational drug SPN-812 demonstrated a significant decrease in ADHD-RS-5 scores compared to placebo.

Higher exposure to air pollutants, especially NO2 and NOx, was found to be associated with greater odds of psychotic experiences in adolescents.

Just 7 other states, and the District of Columbia, have passed such a law before. The bill's parameters are similar to that of Hawaii's, which passed its own law last year.